PROGRESS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL APPS

Recombinant human serum albumin (OsrHSA) has emerged as a substantial innovation in the sector of biopharmaceuticals, featuring promising developments across numerous professional medical and industrial purposes. With its structural similarity to By natural means derived human serum albumin, OsrHSA delivers a safer, additional trusted alternative f